Search Labs

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Core Facilities >

Infante Lab

Our laboratory actively studies disease processes that disrupt normal metabolism.

  • Rodney Infante, M.D., Ph.D
Cell and Molecular Biology

Institute for Exercise and Environmental Medicine (IEEM)

The Institute for Exercise and Environmental Medicine is a 40,000 square-foot research facility with 12 UTSW faculty working in multiple departments and divisions (Internal Medicine/Cardiology/Pulmonary, Neurology, PM&R, Anesthesiology, Applied Physiology) with up to 20 postdocs, and 40 staff on 70 active protocols and 15 federal grants. It is a research enterprise devoted to the study of human physiology and the limits to human functional capacity in health and disease. 

  • Benjamin Levine, M.D.
  • Tony Babb, Ph.D.
  • Craig Crandall, Ph.D.
  • Qi Fu, M.D., Ph.D.
  • Rong Zhang, Ph.D.
  • Tom Sarma, M.D.
  • James MacNamara, M.D.
  • Christopher M. Hearon, Jr., Ph.D.
  • Renie Guilliod, M.D.
  • James Berry, M.D.
  • Andrew Tomlinson, M.D.

Interventional Psychiatry Research Program

Interventional psychiatry is treatment that combines brain stimulation with medication for difficult-to-treat mental health disorders. At UT Southwestern Medical Center, our psychiatrists have advanced training and expertise in caring for people with treatment-resistant mental health disorders.

We specialize in the latest advances in brain stimulation to bring relief to people who haven’t had success with traditional treatments.

  • Shawn McClintock, Ph.D.
  • Hila Abush Segev, Ph.D.
Clinical Psychology

Isogai Lab

We seek to understand how cancer cells harness the cytoskeleton to promote tumor growth, drug resistance and cancer metastasis through non-genetic, morphologic signaling programs.

  • Tadamoto Isogai, Ph.D.
Cancer Biology

Izumi Lab

In the Izumi Lab, with the ultimate goal of identifying druggable molecules/pathways in pediatric genetic disorders, we investigate the molecular mechanisms of pediatric genetic disorders due to chromosomal abnormalities and chromatin protein mutations. We employ novel genetic approaches by using patient-derived samples, induced pluripotent stem cell models and mutant mouse models.

  • Kosuke Izumi, M.D., Ph.D.
Genetics, Development and Disease